$52.66
-5.40 (-9.30%)
At Close: Jun 03, 2026
S&P 500 Sell-Off: 2 No-Brainer Artificial Intelligence (AI) Stocks to Buy With $1,000 Right Now
05:32am, Thursday, 15'th Aug 2024
The S&P 500 hit a patch of volatility in July and August, after a smooth run higher in the first half of 2024. Stock market corrections are almost always a buying opportunity for investors.
Lemonade to Present at Oppenheimer's 27th Annual Technology, Internet & Communications Conference
02:42pm, Saturday, 10'th Aug 2024
NEW YORK--(BUSINESS WIRE)--Lemonade (NYSE: LMND), the digital insurance company powered by AI and social impact, today announced that Chief Financial Officer, Tim Bixby, is scheduled to present at Opp
Wall Street Analysts Are Bearish on This Artificial Intelligence (AI) Stock. Here's Why I'm Not.
10:21am, Saturday, 10'th Aug 2024
Analysts often focus on short-term trends, missing the long-term potential of innovative business ideas. Bearish views on insurance disruptor Lemonade could be a major oversight right now.
Is Lemonade Stock a Buy?
07:45am, Saturday, 10'th Aug 2024
Lemonade is a fast-growing insurer that leverages AI to write insurance policies. The company's loss ratios are improving, showing that its underwriting models are improving.
1 Magnificent Artificial Intelligence (AI) Stock to Buy Hand Over Fist in August
09:53am, Wednesday, 07'th Aug 2024
Lemonade is one of only a few companies successfully monetizing artificial intelligence (AI) at the moment. The company just reported its financial results for the second quarter of 2024, and it made
Looking to Buy Lemonade Stock? Here Are 3 Things You Must Know
06:49am, Tuesday, 06'th Aug 2024
The market likely wasn't pleased with management's Q3 revenue forecast. Lemonade's ultimate potential might be capped, as larger rivals invest in their own tech efforts.
3 Reasons to Buy Lemonade Stock Right Now
04:15am, Tuesday, 06'th Aug 2024
Revenue isn't growing as fast as investors might want to see, but Lemonade is an insurance stock, and it works differently than other tech stocks. Profitability is improving, and loss ratio is stabili
3 Growth Stocks to Buy Hand Over Fist in August
08:37pm, Monday, 05'th Aug 2024
Lemonade's loss ratio is finally coming down. SoFi's non-lending segments are growing as a percentage of the business.
Q3's Rising Stars 3 AI Stocks for Your Must-Watch List
06:56am, Friday, 02'nd Aug 2024
As we progress through 2024, there continues to be many AI stocks to watch. The surge in AI applications, particularly in generative AI and machine learning, has created lucrative opportunities for in
Lemonade's ‘Tech Obsession' Sees AI Handling 30% of Interactions
02:43pm, Wednesday, 31'st Jul 2024
Digital insurance provider Lemonade is continuing to incorporate artificial intelligence (AI) into its business. “Investors and analysts often ask about the practical impact of our investments in
Why Lemonade Stock Was Turning Sour Today
01:32pm, Wednesday, 31'st Jul 2024
Lemonade's high-growth days seem to be coming to an end. The company is still operating at a wide loss.
Lemonade: Focus On Long-Term Metrics, Ignore Short-Term Volatility
12:24pm, Wednesday, 31'st Jul 2024
Shares of Lemonade have tanked ~15% after reporting Q2 results, owing mostly to a softer revenue guidance for Q3. For Lemonade, however, the core metric to watch is in force premium growth, for which
Lemonade Shares Plummet After Earnings. Here's Why I'm Buying More
10:52am, Wednesday, 31'st Jul 2024
A big milestone has been reached.
Compared to Estimates, Lemonade (LMND) Q2 Earnings: A Look at Key Metrics
08:30pm, Tuesday, 30'th Jul 2024
Although the revenue and EPS for Lemonade (LMND) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street
Lemonade (LMND) Reports Q2 Loss, Lags Revenue Estimates
06:55pm, Tuesday, 30'th Jul 2024
Lemonade (LMND) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to loss of $0.97 per share a year ago.
Sign In
Buy LMND